Target intelligence / Profile preview

SARS-CoV-2 Spike Glycoprotein N-terminal Domain (NTD)

Target
NTD
Molecular classification
Glycoprotein, Viral protein
01

Overview

The SARS-CoV-2 spike glycoprotein N-terminal domain (NTD) is a region within the S1 subunit of the spike protein. It features a galectin-like β-sandwich fold and is heavily glycosylated. While its precise function is still under investigation, it is implicated in initial attachment to host cells, immune evasion, and conformational changes required for viral entry. The NTD is a target for neutralizing antibodies and plays a key role in the host immune response to SARS-CoV-2.

02

Mechanism of action

Neutralization of viral entry by antibody binding

03

Biological functions

Viral entryInitial attachment to host cellsImmune evasionConformational dynamics
04

Disease associations

Infection
05

Safety considerations

Antigenic drift leading to escape mutationsPotential for antibody-dependent enhancement (ADE)

Beyond the preview

Go deeper on SARS-CoV-2 Spike Glycoprotein N-terminal Domain (NTD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARS-CoV-2 Spike Glycoprotein N-terminal Domain (NTD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call